Belgium· BE-AMP-SAM442303-00
Moxifloxacin Apotex 400 mg
A moxifloxacin product containing moxifloxacin hydrochloride, registered in Belgium by Apotex Europe. The same ATC class is registered in 16 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Moxifloxacin is registered in 16 of 19 countries.
Countries holding a registration under ATC J01MA14 (moxifloxacin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Moxifloxacin · ATC J01MA14
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of moxifloxacin costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $1.34 in United States to $6.89 in Switzerland — a ×5.2 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Moxifloxacin · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$6.89
- IT Italy$1.99
- US United States$1.34 (acquisition cost)
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Moxifloxacin Hydrochloride
- Manufacturer
- Apotex Europe
- Country
- Belgium (BE)
- ATC code
- J01MA14
- ATC class
- Moxifloxacin
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 3
- be_apb3117470
- be_apb7706807
- be_apb3117488
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
531 interactions on record for moxifloxacin.
Graded by severity as the source publishes them — 175 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Moxifloxacin · interactions on record
531 records
- 175 severe
- 140 moderate
- 49 minor
- 92 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
75 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Moxifloxacin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMoxifloxacinDr. Reddy's Laboratories Limited
- SpainABIOX 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGTiedra Farmaceutica S.L.
- SwitzerlandAvalox
- FinlandActiraBayer HealthCare AG
- FranceIZILOX 400 mg, comprimé pelliculéBAYER HEALTHCARE
- PolandKimoksAlkaloid - INT d.o.o.
- SwedenAvelox 400 mg Filmdragerad tablettBayer AB
- ItalyAVALOXBAYER S.P.A.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Avelox, Moxifloxacin 1a Pharma
- Bulgaria · Cimocinox, Moxifloxacin Kabi
- Cyprus · Avelox, Erelan
- Czechia · Avelox, Moxifloxacin Brown & Burk
- Germany · Avalox, Moxifloxacin 1 A Pharma
- Denmark · Moxifloxacin Accord, Moxifloxacin Fresenius Kabi
- Estonia · Avelox, Floxelan
- Spain · Abimox, Actira
- Finland · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
- France · Izilox, Moxifloxacine Arrow
- United Kingdom (Northern Ireland) · Avelox, Moxidox
- Greece · Avelox, Mikrobiel
- Croatia · Melvedok, Moksacin 5 Mg/Ml Kapi
- Hungary · Moxibiot, Moxifloxacin Anfarm
- Ireland · Moxifloxacin
- Iceland · Vigamox
- Italy · Avalox, Moxidrop
- Lithuania · Avelox, Ekara
- Luxembourg · Avelox, Kanavig
- Latvia · Avelox, Ekara
- Malta · Erelan, Moxifloxacin Anfarm
- Netherlands · Erelan, Moxifloxacin Hydrochloride Aurobindo
- Norway · Xinaflox
- Poland · Flomixa, Floxamic Neo
- Portugal · Avelox, Bluesar
- Romania · Avelox, Kimoks
- Sweden · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
- Slovenia · Kimoks, Moksifloksacin Kabi
- Slovakia · Avelox, Moloxin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4b21651-8aab-4e72-a754-0f563bef6e69 GET /v1/drugs/f4b21651-8aab-4e72-a754-0f563bef6e69?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Moxifloxacin Apotex 400 mg",
"name_fr": "Moxifloxacin Apotex 400 mg",
"name_nl": "Moxifloxacin Apotex 400 mg",
"amp_code": "SAM442303-00",
"strengths": [
"436.3300",
"436.3300",
"400.0000",
"400.0000"
],
"pack_count": 4,
"substances": [
"Moxifloxacin Hydrochloride",
"Moxifloxacin"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Moxifloxacin",
"authorisation_numbers": [
"BE442303"
]
}See everything about moxifloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.